rs3820246
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_018012.4(KIF26B):c.3444G>A(p.Pro1148Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0215 in 1,613,346 control chromosomes in the GnomAD database, including 1,586 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.026 ( 176 hom., cov: 33)
Exomes 𝑓: 0.021 ( 1410 hom. )
Consequence
KIF26B
NM_018012.4 synonymous
NM_018012.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.65
Genes affected
KIF26B (HGNC:25484): (kinesin family member 26B) The protein encoded by this gene is an intracellular motor protein thought to transport organelles along microtubules. The encoded protein is required for kidney development. Elevated levels of this protein have been found in some breast and colorectal cancers. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-245686427-G-A is Benign according to our data. Variant chr1-245686427-G-A is described in ClinVar as [Benign]. Clinvar id is 403008.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-245686427-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.65 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.101 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIF26B | ENST00000407071.7 | c.3444G>A | p.Pro1148Pro | synonymous_variant | 12/15 | 1 | NM_018012.4 | ENSP00000385545.2 | ||
KIF26B | ENST00000366518.4 | c.2301G>A | p.Pro767Pro | synonymous_variant | 9/12 | 5 | ENSP00000355475.4 | |||
KIF26B | ENST00000483253.1 | n.1375G>A | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0257 AC: 3903AN: 152116Hom.: 169 Cov.: 33
GnomAD3 genomes
AF:
AC:
3903
AN:
152116
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0488 AC: 12143AN: 248938Hom.: 1055 AF XY: 0.0416 AC XY: 5626AN XY: 135198
GnomAD3 exomes
AF:
AC:
12143
AN:
248938
Hom.:
AF XY:
AC XY:
5626
AN XY:
135198
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0210 AC: 30712AN: 1461110Hom.: 1410 Cov.: 51 AF XY: 0.0203 AC XY: 14777AN XY: 726860
GnomAD4 exome
AF:
AC:
30712
AN:
1461110
Hom.:
Cov.:
51
AF XY:
AC XY:
14777
AN XY:
726860
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0258 AC: 3932AN: 152236Hom.: 176 Cov.: 33 AF XY: 0.0277 AC XY: 2063AN XY: 74428
GnomAD4 genome
AF:
AC:
3932
AN:
152236
Hom.:
Cov.:
33
AF XY:
AC XY:
2063
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
257
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
KIF26B-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 05, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at